 |
0 Diseases |  |
0 Trials |
|
0 Trials |  |
3 News |  |
- | ALD 401 / Nuo Therapeutics
Clinical, P2 data, Journal: A Phase 2 Randomized, Sham Controlled Trial of Internal Carotid Artery Infusion of Autologous Bone Marrow Derived ALD-401 Cells in Patients with Recent Stable Ischemic Stroke (RECOVER-Stroke). (Pubmed Central) - Oct 24, 2019
P2
There was no difference in the primary efficacy endpoint between the groups. The study provides a frame-work for the design and conduct of future intra-arterial cell therapy trials in stroke.
- ||| ALD 401 / Nuo Therapeutics
Enrollment closed: Study of ALD-401 Via Intracarotid Infusion in Ischemic Stroke Subjects (clinicaltrials.gov) - Jan 13, 2014
P2, N=100, Active, not recruiting, Sponsor: Aldagen
The study provides a frame-work for the design and conduct of future intra-arterial cell therapy trials in stroke. Recruiting --> Active, not recruiting